Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
Author(s) -
Christine Wu,
Parmjeet Randhawa,
Jerry McCauley
Publication year - 2006
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2006.93
Subject(s) - immunosuppression , bk virus , medicine , transplantation , kidney transplantation , nephropathy , genitourinary system , disease , polyomavirus infections , kidney , intensive care medicine , immunology , urology , endocrinology , diabetes mellitus
BK virus is ubiquitously present in the latent state in humans, and awareness of the importance of BK polyomavirus is emerging among the kidney transplant community. First discovered in 1971 in the urine of a renal transplant recipient, BK virus nephropathy (BKVN) has come to be recognized as a significant cause of genitourinary disease and potential graft loss in the kidney transplant patient. In this review, we discuss the risk factors, available methods of diagnosis and therapeutic monitoring, and current approaches to therapy of BKVN.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom